抄録／抄録１ （１）Ｖ
|
|
|
- きみとし あくや
- 2 years ago
- Views:
Transcription
1
2
3
4
5 β β
6 !
7
8
9 "!
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34 β β β β β γ γ γ
35
36 β β β β β β β β β β β β β β β β
37
38
39
40
41
42
43
44
45
46 !
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78 !
79
80 !
81
82
83
84 µ
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
第86回日本感染症学会総会学術集会後抄録（I）
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
2 7 ( ) µ 
ｎｓｇ０４－２８／ｋｙ２０８６８４３５６１０００４３０７７
δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!
10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1
4 16 1 10:0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!! 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 ! 2 10:0010 : 28 1F Annex 1 3 15:0015 : 28 1F Annex 1 4 10:3010 : 58 1F Annex 1 1 15:3015
_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
ｎｓｇ０２－１３／ｋｙ０４５０５９３０１６０００３３２１０
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
日歯雑誌（Ｈ２８・８月号）別刷り／ポスターセッション とびら
α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α
3/4/8:9 { } { } β β β α β α β β
α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3
内科９６巻３号★／ＮＡＩ３‐１（第２２回試験問題）
µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2
研修コーナー
l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,
日本医科大学医学会雑誌第8巻第1号
Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1
日本分子第5巻2号_15特別講演・シンポジウム.indd
25 JSMI Report JSMI Report 26 41 JSMI Report JSMI Report 42 JSMI Report 54 55 JSMI Report JSMI Report 56 57 JSMI Report JSMI Report 58 59 JSMI Report JSMI Report 60 61 JSMI Report β JSMI Report 62 63 JSMI
CVMに基づくNi-Al合金の
CV N-A (-' by T.Koyama ennard-jones fcc α, β, γ, δ β α γ δ = or α, β. γ, δ α β γ ( αβγ w = = k k k ( αβγ w = ( αβγ ( αβγ w = w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( βγδ w = = k k k ( αγδ
感染症学雑誌第77巻第8号
1 2 µ Streptococcus pneumoniae µ S. pneumoniae µ S. pneumoniae pbp β β pbp1a pbp2x pbp2b pbp mefe ermb pbp pbp1a pbp2x pbp2b pbp pbp pbp pbp 2x pbp1a pbp2x pbp 2b mefe ermb pbp β pbp2x β β β µ µ pbp3 µ
202
202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 DS =+α log (Spread )+ β DSRate +γlend +δ DEx DS t Spread t 1 DSRate t Lend t DEx DS DEx Spread DS
.\ /......
教育 研究 社会貢献活動報告 香 川 医 科 大 学 平成１ ３年度 香川医科大学自己点検評価委員会 γ α β β β α β β γ γ α β αβ µ Anopheles Bolbosoma Leishmania Pneumocystis carinii P. carinii Bolbosoma Leishmania Anopheles Plasmodium
‚åŁÎ“·„´Šš‡ðŠp‡¢‡½‹âfi`fiI…A…‰…S…−…Y…•‡ÌMarkovŸA“½fiI›ð’Í
Markov 2009 10 2 Markov 2009 10 2 1 / 25 1 (GA) 2 GA 3 4 Markov 2009 10 2 2 / 25 (GA) (GA) L ( 1) I := {0, 1} L f : I (0, ) M( 2) S := I M GA (GA) f (i) i I Markov 2009 10 2 3 / 25 (GA) ρ(i, j), i, j I
授業研究第1日目
1 1 1 0. (sextant) ( ) 2 1. IB I AB I AI E H H E B GHE CIHE ( ) 2 2 I H A (0 ) ( ) 3 2 2 θ = α + γ β + γ = θ + α β + γ = ( α + γ ) + α β = 2 α + γ γ C H CIG ( ) 4 2. John Hadley 1731 5 ( (octant)) Captain
( )
) ( ( ) 3 15m t / 1.9 3 m t / 0.64 3 m ( ) ( ) 3 15m 3 1.9m / t 0.64m 3 / t ) ( β1 β 2 β 3 y ( ) = αx1 X 2 X 3 ( ) ) ( ( ) 3 15m t / 1.9 3 m 3 90m t / 0.64 3 m ( ) : r : ) 30 ( 10 0.0164
> > <., vs. > x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D > 0 x (2) D = 0 x (3
13 2 13.0 2 ( ) ( ) 2 13.1 ( ) ax 2 + bx + c > 0 ( a, b, c ) ( ) 275 > > 2 2 13.3 x 2 x y = ax 2 + bx + c y = 0 2 ax 2 + bx + c = 0 y = 0 x ( x ) y = ax 2 + bx + c D = b 2 4ac (1) D >
現代物理化学 1-1(4)16.ppt
(pdf) pdf pdf http://www1.doshisha.ac.jp/~bukka/lecture/index.html http://www.doshisha.ac.jp/ Duet -1-1-1 2-a. 1-1-2 EU E = K E + P E + U ΔE K E = 0P E ΔE = ΔU U U = εn ΔU ΔU = Q + W, du = d 'Q + d 'W
TEL-E7
Ni-Cd TEL-E7 TEL-EW7 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 9 20 Ni-Cd 2 3 2 2 3 22 2 2 3 4 3 4 23 2 2 3 3 24 25 2 3 4 2 3 4 26 2 3 2 3 27 2 2 2 28 2 2 2 29 2 3 2 4 30 2 2 3 3 2 3 2 3 3 32 33 2 3 34 2 3 35
喘息について\(公健協会宛02-5作成\)
Q & A Q & A 1.? 20 2. 1) 2) 3) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 8) 9) 3. NHK ( ) 4 10 1 200mg ( ) ( 1 ) 4. ( ) ( ) 5. ( ) ( ) 6. β 2 ( ) 7. ( ) 1 8. 1. 2. 3. 4. 5. 6. 7. 8. 9. 2 5 7 1. 1 10 1) 2) 3) 30
untitled
c OR 21 OR 1. 21 21 IoT OR OR OR 260 8672 1 8 1 OR 2. 2.1 public health [1] communicable (infectious) diseases vehicle burden HIV/AIDS (SARS) 258 60 Copyright c by ORSJ. Unauthorized reproduction of this
A = A x x + A y y + A, B = B x x + B y y + B, C = C x x + C y y + C..6 x y A B C = A x x + A y y + A B x B y B C x C y C { B = A x x + A y y + A y B B
9 7 A = A x x + A y y + A, B = B x x + B y y + B, C = C x x + C y y + C..6 x y A B C = A x x + A y y + A B x B y B C x C y C { B = A x x + A y y + A y B B x x B } B C y C y + x B y C x C C x C y B = A
gr09.dvi
.1, θ, ϕ d = A, t dt + B, t dtd + C, t d + D, t dθ +in θdϕ.1.1 t { = f1,t t = f,t { D, t = B, t =.1. t A, tdt e φ,t dt, C, td e λ,t d.1.3,t, t d = e φ,t dt + e λ,t d + dθ +in θdϕ.1.4 { = f1,t t = f,t {
μ μ μ
TitleLC/MS 法を用いた局所麻酔薬の血中濃度測定 澤木, 康平 ; 大久保, みぎわ ; 四宮, 敬史 ; 塚越, 絵里 ; Author(s) 山﨑, 貴希 ; 劔持, 正浩 ; 宮尾, 真理子 ; 金子, 譲 ; 一 戸, 達也 ; 川口, 充 Journal 歯科学報, 110(3): 347-352 URL http://hdl.handle.net/10130/1699 Right
l µ l µ l 0 (1, x r, y r, z r ) 1 r (1, x r, y r, z r ) l µ g µν η µν 2ml µ l ν 1 2m r 2mx r 2 2my r 2 2mz r 2 2mx r 2 1 2mx2 2mxy 2mxz 2my r 2mz 2 r
2 1 (7a)(7b) λ i( w w ) + [ w + w ] 1 + w w l 2 0 Re(γ) α (7a)(7b) 2 γ 0, ( w) 2 1, w 1 γ (1) l µ, λ j γ l 2 0 Re(γ) α, λ w + w i( w w ) 1 + w w γ γ 1 w 1 r [x2 + y 2 + z 2 ] 1/2 ( w) 2 x2 + y 2 + z 2
免疫Ⅱ
100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC
untitled
.m 5m :.45.4m.m 3.m.6m (N/mm ).8.6 σ.4 h.m. h.68m h(m) b.35m θ4..5.5.5 -. σ ta.n/mm c 3kN/m 3 w 9.8kN/m 3 -.4 ck 6N/mm -.6 σ -.8 3 () :. 4 5 3.75m :. 7.m :. 874mm 4 865mm mm/ :. 7.m 4.m 4.m 6 7 4. 3.5
kogi dvi
10 4 23 ( ) email: tanikawa.ky@nao.ac.jp I. ( ) II. : III. ( ) 1 I. : ( ) :, : :, :? : = : =, ( ). 2 1.... ( ).. (,,,, ),,, ( ) ( ). ( )... ( ).?. 3 1: ( T)... 19 F.R. Stephenson 1990 ΔT 4 II. : (i) (ii))
2 FIG. 1: : n FIG. 2: : n (Ch h ) N T B Ch h n(z) = (sin ϵ cos ω(z), sin ϵ sin ω(z), cos ϵ), (1) 1968 Meyer [5] 50 N T B Ch h [4] N T B 10 nm Ch h 1 µ
![2 FIG. 1: : n FIG. 2: : n (Ch h ) N T B Ch h n(z) = (sin ϵ cos ω(z), sin ϵ sin ω(z), cos ϵ), (1) 1968 Meyer [5] 50 N T B Ch h [4] N T B 10 nm Ch h 1 µ](/thumbs/49/25515566.jpg "2 FIG. 1: : n FIG. 2: : n (Ch h ) N T B Ch h n(z) = (sin ϵ cos ω(z), sin ϵ sin ω(z), cos ϵ), (1) 1968 Meyer [5] 50 N T B Ch h [4] N T B 10 nm Ch h 1 µ")
: (Dated: February 5, 2016), (Ch), (Oblique Helicoidal) (Ch H ), Twist-bend (N T B ) I. (chiral: ) (achiral) (n) (Ch) (N ) 1996 [1] [2] 2013 (N T B ) [3] 2014 [4] (oblique helicoid) 2016 1 29 Electronic
日本皮膚科学会雑誌第120巻第5号
1 2 3 4 5 6 A B 1 2 α β 3 表 1 ClinicalQuestion CQ1 男性型脱毛症にミノキシジルの外用は有用か? (CQ1.1) 男性の男性型脱毛症 (CQ1.2) 女性の男性型脱毛症 CQ2 男性型脱毛症に塩化カルプロニウムの外用は有用か? CQ3 男性型脱毛症に医薬部外品 化粧品の育毛剤の外用は有用か? CQ3.1t- フラバノン CQ3.2 アデノシン CQ3.3
untitled
(a) (b) (c) (d) Wunderlich 2.5.1 = = =90 2 1 (hkl) {hkl} [hkl] L tan 2θ = r L nλ = 2dsinθ dhkl ( ) = 1 2 2 2 h k l + + a b c c l=2 l=1 l=0 Polanyi nλ = I sinφ I: B A a 110 B c 110 b b 110 µ a 110
untitled
. 96. 99. ( 000 SIC SIC N88 SIC for Windows95 6 6 3 0 . amano No.008 6. 6.. z σ v σ v γ z (6. σ 0 (a (b 6. (b 0 0 0 6. σ σ v σ σ 0 / v σ v γ z σ σ 0 σ v 0γ z σ / σ ν /( ν, ν ( 0 0.5 0.0 0 v sinφ, φ 0 (6.
現代物理化学 2-1(9)16.ppt
--- S A, G U S S ds = d 'Q r / ΔS = S S = ds =,r,r d 'Q r r S -- ds = d 'Q r / ΔS = S S = ds =,r,r d 'Q r r d Q r e = P e = P ΔS d 'Q / e (d'q / e ) --3,e Q W Q (> 0),e e ΔU = Q + W = (Q + Q ) + W = 0
[ ] = L [δ (D ) (x )] = L D [g ] = L D [E ] = L Table : ħh = m = D D, V (x ) = g δ (D ) (x ) E g D E (Table )D = Schrödinger (.3)D = (regularization)
![[ ] = L [δ (D ) (x )] = L D [g ] = L D [E ] = L Table : ħh = m = D D, V (x ) = g δ (D ) (x ) E g D E (Table )D = Schrödinger (.3)D = (regularization)](/thumbs/47/23763429.jpg "[ ] = L [δ (D ) (x )] = L D [g ] = L D [E ] = L Table : ħh = m = D D, V (x ) = g δ (D ) (x ) E g D E (Table )D = Schrödinger (.3)D = (regularization)")
. D............................................... : E = κ ............................................ 3.................................................
(I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 Typeset by Akio Namba usig Powerdot. 2 / 47
4 Typeset by Akio Namba usig Powerdot. / 47 (I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 Typeset by Akio Namba usig Powerdot. 2 / 47 (I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 (radom variable):
表1表4.indd
The Journal of The Toyaku CONTENTS Vol.31 No.3 March 2009 出版委員会の活動について Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009 Vol 31No.32009
根治的手術を施行し得た同時性重複癌 ( 進展舌癌と食道 Title 癌 ) の1 例 千葉, 哲彦 ; 岩本, 昌士 ; 齊藤, シオン ; 八木澤, 潤子 ; Author(s) 野本, 俊太郎 ; 市川, 秀樹 ; 成田, 真人 ; 伊藤, 亜希 ; 松崎, 英雄 ; 田中, 潤一 ; 髙野, 伸夫 Journal 歯科学報, 109(2): 192-200 URL http://hdl.handle.net/10130/912
日医雑誌第126巻第9号
[] HIV 4 sexually transmitted diseases 1975 WHO 12 3 2 5 3 1 1 4 3 40 1 1947 4 WHO 1975 STDsexually transmitted diseases STIsexually transmitted infection 5 STD 5 10 20 5 5 HIV STD RTIreproductive tract
kawa (Spin-Orbit Tomography: Kawahara and Fujii 21,Kawahara and Fujii 211,Fujii & Kawahara submitted) 2 van Cittert-Zernike Appendix A V 2
Hanbury-Brown Twiss (ver. 1.) 24 2 1 1 1 2 2 2.1 van Cittert - Zernike..................................... 2 2.2 mutual coherence................................. 3 3 Hanbury-Brown Twiss ( ) 4 3.1............................................
Γ Ec Γ V BIAS THBV3_0401JA THBV3_0402JAa THBV3_0402JAb 1000 800 600 400 50 % 25 % 200 100 80 60 40 20 10 8 6 4 10 % 2.5 % 0.5 % 0.25 % 2 1.0 0.8 0.6 0.4 0.2 0.1 200 300 400 500 600 700 800 1000 1200 14001600
β β β β β β
β β β β β β β β β β β β β β β β β θ β α γ et al et al et al β β et al β et al in vivo et al γ et al et al et al et al et al et al Ectopic fat deposition, type 2 diabetes mellitus and cardiovascular diseases
t sex N y y y Diff (1-2)
Armitage 1 1.1 2 t 1.2 SAS Proc GLM 2 2.1 1 1 2.1.1 50 1 1 t sex N y 50 116.45 119.6 122.75 11.071 1.5657 93.906 154.32 y 50 127.27 130.7 134.13 12.072 1.7073 102.68 163.37 y Diff (1-2) -15.7-11.1-6.504
p.2/76
kino@info.kanagawa-u.ac.jp p.1/76 p.2/76 ( ) (2001). (2006). (2002). p.3/76 N n, n {1, 2,...N} 0 K k, k {1, 2,...,K} M M, m {1, 2,...,M} p.4/76 R =(r ij ), r ij = i j ( ): k s r(k, s) r(k, 1),r(k, 2),...,r(k,
I-2 (100 ) (1) y(x) y dy dx y d2 y dx 2 (a) y + 2y 3y = 9e 2x (b) x 2 y 6y = 5x 4 (2) Bernoulli B n (n = 0, 1, 2,...) x e x 1 = n=0 B 0 B 1 B 2 (3) co
16 I ( ) (1) I-1 I-2 I-3 (2) I-1 ( ) (100 ) 2l x x = 0 y t y(x, t) y(±l, t) = 0 m T g y(x, t) l y(x, t) c = 2 y(x, t) c 2 2 y(x, t) = g (A) t 2 x 2 T/m (1) y 0 (x) y 0 (x) = g c 2 (l2 x 2 ) (B) (2) (1)
_FH28_J.qxd
23.9 + + ø ø ø ø ø ø ø ø ø ++ + ++ + + + ± FH 28 D - 5 (25) S B -.5 SH (5) 2 3 4 5 6 7 8 9 2 6 7 3 8 4 9 5 ** ** ** ** ** ** ** ** ** ** ** ** ** CL586-86-4-** CL586-868-3-** CL586-823-5-** CL586-835-4-**
T1 T2 T3 T4 350 mm φ21 100 3.5 15wt% 0wt% 3.0 80 2.5 10wt% 60 2.0 5wt% 5wt% 40 1.5 1.0 10wt% 20 15wt% 0.5 0wt% 0 0.0 100 200 300 400 100 200 300 400 [μm] [μm] [%] [] = 0.9 = 0.5 = 0.1 ( =1.0) FDTD p/λ
22 / ( ) OD (Origin-Destination)
23 2 15 22 / ( ) OD (Origin-Destination) 1 1 2 3 2.1....................................... 3 2.2......................................... 3 2.3.......................................... 5 2.4............................
溶血性尿毒症症候群 ver 最終.pptx
Hemolytic uremic syndrome(hus) ver0130525 (HUS), Stx VT 3 3 1. ( Hb10g/dl ) 2. ( 10 /µl ) 3. ( 97.5 ) 1.5 ) (HUS) D+HUS D-HUS(aHUS) HUS ahus ( 6 HUS ( ) HUS HUS ahus O-157 9-30 HUS 15 80 5 5 10 2-3 (O-157
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - 20log10 150 = 44 20log10 150 = 44-7 - - 8 - - 9 - - 10 - L ks X n + X 2 2 ) ( 1) ( 1 = X X n S n n n X L k k n X n X S n L n k - 11 - - 12 - - 13 - - 14 - - 15 - - 16
日本呼吸器学会雑誌第44巻第7号
Table1Laboratoryfindingsonadmission Hematology Serology LungFunctionTest WBC 7,410 /μl CRP 7.7mg/dl VC 3.12L(97.2%) Neut 66.4 % KL-6 777U/ml FEV1.0 2.35L(78.25%) Eosino 3.2 % PT (INR) 0.94 %DLCO 47.6 %
KamLAND (µ) ν e RSFP + ν e RSFP(Resonant Spin Flavor Precession) ν e RSFP 1. ν e ν µ ν e RSFP.ν e νµ ν e νe µ KamLAND νe KamLAND (ʼ4). kton-day 8.3 < E ν < 14.8 MeV candidates Φ(νe) < 37 cm - s -1 P(νe
34回呼吸器内視鏡学会_日程1日目
6 16 1 1F 8:008:40 8:4010 : 00 10 : 0010 : 30 10 : 3011 : 10 11 : 1011 : 50 11 : 5012 : 20 14 : 5016 : 50 3 4F 41 8:4010 : 00 12 : 3013 : 30 14 : 5015 : 30 15 : 3017 : 00 19 : 0020 : 40 4 4F 4344 8:409:28
住宅ローンのリスク管理
NSSOL & CPC 2008 (p.23) Credit Pricing Corp. @ Now Printing PD i 1 i 2 t = 1 α t Now Printing T i i i 1 1 2 2 n n T exp( βx ) βx = β x + β x + Lβ x x i DTI x i Now Printing Now Printing Now Printing
Japan Research Review 1998年7月号
Japan Research Review 1998.7 Perspectives ****************************************************************************************** - 1 - Japan Research Review 1998.7-2 - Japan Research Review 1998.7-3
untitled
.. 3. 3 3. 3 4 3. 5 6 3 7 3.3 9 4. 9 0 6 3 7 0705 φ c d φ d., φ cd, φd. ) O x s + b l cos s s c l / q taφ / q taφ / c l / X + X E + C l w q B s E q q ul q q ul w w q q E E + E E + ul X X + (a) (b) (c)